Brian Shea

Biography

Brian Shea currently serves as Head of Legal at Newleos Therapeutics, a Boston-based biopharmaceutical company developing novel drugs for neuropsychiatric disorders, where he is responsible for legal and compliance matters. Brian brings more than 10 years of experience working in the life sciences and biotech industry, with particular focus on strategic transactions and governance matters, public company and stock exchange compliance. Prior to Newleos, Brian served as Vice President, Legal at uniQure (Nasdaq: QURE), a Netherlands-based developer of gene therapies to treat rare disease, where he led the company’s corporate legal and compliance function. Before uniQure, Brian was General Counsel of Oncorus (Nasdaq: ONCR), a Boston-based biopharmaceutical company developing RNA-based immunotherapies to treat various forms of cancer. He assumed the role of Interim CEO at Oncorus to manage the orderly wind down and dissolution of the company.

Prior to his in-house roles, Brian practiced in the strategic transactions group at Ropes & Gray, representing late-stage private and public companies and investment banks in going-public transactions, strategic financings and securities law compliance. Prior to that, Brian was a corporate associate at Mintz Levin. Brian holds a B.A. from Dartmouth College and a J.D. from William & Mary Law School, and currently serves on the William & Mary Law School Alumni Association Board of Directors.